English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Boehringer Ingelheim
Robert Hadley
| Jun 28, 2017
Pradaxa study highlights need for early diagnosis of atrial fibrillation
Ruth de Jauregui
| Jun 2, 2017
Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients
Ruth de Jauregui
| May 31, 2017
Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients
Gene Johnson
| Mar 10, 2017
Boehringer Ingelheim, Vanderbilt University partner to expand cancer research
Carol Ostrow
| Nov 27, 2016
‘Sweetheart’ survey reveals need for health education among type 2 diabetes patients
Amanda Rupp
| Oct 2, 2016
Boehringer Ingelheim partners with ViraTherapeutics for immuno-oncology project
Amanda Rupp
| Sep 6, 2016
Experts develop largest IPF patient registry yet
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
